Big Pharma – Bigger Data

Big Pharma – Bigger Data main image

70% of companies that specialize in clinical trials had problems collaborating remotely during the pandemic, studies indicate.

This has led to digitalization of clinical trials. With the support of digital tools, the industry transformed to hybrid or virtual clinical trials.

While these approaches were field-tested in developing vaccines, they showcase a way forward in improving routine clinical trial studies.

Read the full article: